Abstract
Human medicines European public assessment report (EPAR): Onivyde, irinotecan hydrochloride trihydrate, Pancreatic Neoplasms, Date of authorisation: 14/10/2016, Revision: 3, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have